Last update:

Overweight & Obesity news

Overweight & Obesity

Key enzyme controls both weight gain and cholesterol levels in animal models

Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, including heart disease and fatty liver disease (MASLD). Rates of these disorders have risen as the ...

Medications

Novo Nordisk says US approves first GLP-1 pill for weight loss

Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight loss.

Overweight & Obesity

Ret finger protein: A hidden molecular switch that fuels obesity

Obesity is one of the greatest burdens of global public health. One major factor that drives obesity is excessive fat accumulation. Despite decades of research, the biological processes that trigger this abnormal fat accumulation ...

Overweight & Obesity

States retreat from covering drugs for weight loss

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for the cuts included in President Donald Trump's broad tax and spending law.

Psychology & Psychiatry

One short quiz could help people stick to their weight loss plans

A new study, published in JMIR Formative Research, has found that people who answered a brief quiz to determine their "eating profile" were more likely to stick with their program and stay committed to their weight loss goals ...

Overweight & Obesity

COVID-19 pandemic linked to increases in childhood obesity

The COVID-19 pandemic not only disrupted children's education, recreation, and social lives, but it also increased the prevalence of obesity in the U.S. pediatric population by roughly 1 million youngsters, according to a ...

Alzheimer's disease & dementia

Blood test shows obesity speeds Alzheimer's development

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in non-obese individuals, ...

Overweight & Obesity

WHO backs GLP-1 treatments to tackle obesity epidemic

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which affects over one billion people worldwide, the World Health Organization said Monday.

Medications

WHO recommends Ozempic-style weight loss drugs for obesity

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic burden.